About: Racura Oncology Ltd operates as a clinical-stage biopharmaceutical company in Australia. It develops RC220, a formulation of (E,E)-bisantrene, which is in Phase III clinical trial for the treatment of acute myeloid leukemia; Phase Ia/b clinical trial for the treatment of epidermal growth factor receptor-mutated non-small cell lung cancer; and Phase Ia/b clinical trial for the treatment of solid tumor cancers. The company was formerly known as Race Oncology Limited and changed its name to Racura Oncology Ltd in December 2025. Racura Oncology Ltd was incorporated in 2011 and is headquartered in Sydney, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$1.77 (-4.58%)
RAC ASX Race Oncology Ltd
Race Oncology Ltd share price
RAC price activity
Último preço
$ 1,800
Variação (24h)
-0,06 AUD (-2,97%)
Volume
96.07K
Volume (média 4 sem.)
-
Abertura
$ 1,86
Variação do dia
$ 1,77 - $ 1,86
Fechamento anterior
$ 1,86
Último negócio
06 Oct, 11:11 pm GMT+0
Atrasado
06 Oct, 11:11 pm GMT+0
RAC price performance
Atrasado
06 Oct, 11:11 pm GMT+0
quote.marketSignals